Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades912
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions2
HIK
Media
HIK Company
Research
HIK Company
Timeline2
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
1,531.00
1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread:
1.00 (0.065%)
Market Cap:
£3.22b
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
26 Jan 2021
TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia
TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia
12 Jan 2021
Vectura Forecasts 2020 Earnings To Top Board Expectations
Vectura Forecasts 2020 Earnings To Top Board Expectations
18 Dec 2020
LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
18 Dec 2020
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
18 Dec 2020
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
18 Dec 2020
Hikma rallies as it launches generic version of Glaxo asthma treatment
(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and l...
17 Dec 2020
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
2 Dec 2020
Wednesday broker round-up
(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.
Follow the stocks
